{"title":"Role of CD163 in the mechanism of hydrophilic silica nanoparticle-induced pulmonary fibrosis","authors":"Chaoya Ma, Yaotang Deng, Xiao Zhang, Qifeng Wu, Fengrong Lu, Jin Wu, Ying Zhang, Cuiju Wen","doi":"10.1016/j.tiv.2026.106201","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Silicosis, a progressive pulmonary fibrosis caused by silica dust exposure, remains a global occupational health threat, particularly with the rising use of nano-silica (nano-SiO₂) in industries. This study aims to explore the role of CD163 in pulmonary fibrosis induced by nano-silica (nano-SiO₂), and to evaluate its potential as a diagnostic biomarker by combining clinical analysis of patients with silicosis and in vitro validation models.</div></div><div><h3>Method</h3><div>Gene expression in BALF from stage I silicosis patients was analyzed by PCR. In vitro, THP-1-derived macrophages and MRC-5 fibroblasts were exposed to 100 μg/mL nano-SiO₂ (LC<sub>50</sub>) in mono- and co-culture systems. CD163, CD68, and TNF-α levels were quantified via ELISA and Western blot.</div></div><div><h3>Result</h3><div>In patients, M2 markers (CD163/CD68) were upregulated, while M1 gene (TNF) was downregulated. In vitro, nano-SiO₂ increased macrophage CD163 by 1.7 times (<em>P</em> < 0.05) and decreased TNF-α by 42%. Co-culture further increased CD163 by 2.1 times (<em>P</em> < 0.01), indicating amplified M2 polarization via crosstalk.</div></div><div><h3>Conclusion</h3><div>Nano-SiO₂ drives M2 polarization (CD163↑/TNF-α↓). This finding suggests that CD163 may become one of the potential biomarkers for assessing the risk of pulmonary fibrosis induced by nano-SiO₂, providing important clues for the early warning and mechanism research of silicosis.</div></div>","PeriodicalId":54423,"journal":{"name":"Toxicology in Vitro","volume":"113 ","pages":"Article 106201"},"PeriodicalIF":2.7000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology in Vitro","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0887233326000093","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Silicosis, a progressive pulmonary fibrosis caused by silica dust exposure, remains a global occupational health threat, particularly with the rising use of nano-silica (nano-SiO₂) in industries. This study aims to explore the role of CD163 in pulmonary fibrosis induced by nano-silica (nano-SiO₂), and to evaluate its potential as a diagnostic biomarker by combining clinical analysis of patients with silicosis and in vitro validation models.
Method
Gene expression in BALF from stage I silicosis patients was analyzed by PCR. In vitro, THP-1-derived macrophages and MRC-5 fibroblasts were exposed to 100 μg/mL nano-SiO₂ (LC50) in mono- and co-culture systems. CD163, CD68, and TNF-α levels were quantified via ELISA and Western blot.
Result
In patients, M2 markers (CD163/CD68) were upregulated, while M1 gene (TNF) was downregulated. In vitro, nano-SiO₂ increased macrophage CD163 by 1.7 times (P < 0.05) and decreased TNF-α by 42%. Co-culture further increased CD163 by 2.1 times (P < 0.01), indicating amplified M2 polarization via crosstalk.
Conclusion
Nano-SiO₂ drives M2 polarization (CD163↑/TNF-α↓). This finding suggests that CD163 may become one of the potential biomarkers for assessing the risk of pulmonary fibrosis induced by nano-SiO₂, providing important clues for the early warning and mechanism research of silicosis.
期刊介绍:
Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal will focus on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterise the relationship between in vitro and in vivo findings. The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals). Toxicology in Vitro discourages papers that record reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.